PEAK6
MED icon

PEAK6’s Medifast MED Stock Holding History

PEAK6’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,426
Closed -$80.1K – 3056
2025
Q4 		$79.3K Buy
+7,426
New +$88.9K ﹤0.01% 2545

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

PEAK6's MED Position: Q1 2026 in Review

PEAK6 sold out of Medifast (MED) in Q1 2026, closing a stake of 7,426 shares — an estimated $80.1K sold.

PEAK6 first reported a position in MED in Q4 2025 and held it in 1 quarter. The position peaked at $79.3K in Q4 2025. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • PEAK6 reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
  • PEAK6 sold 7,426 Medifast shares in Q1 2026, an estimated $80.1K.
  • PEAK6 first reported a position in Medifast in Q4 2025 and held it in 1 quarter.
  • PEAK6's Medifast position peaked at $79.3K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.